Dermata Therapeutics, Inc. (DRMA) Stock Ticker
DRMA right now
Market factors today
Unlock the full DRMA picture
About Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
DRMA stock facts
| Ticker symbol | DRMA |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $776,975 |
| CEO | Gerald T. Proehl |
| Employees | 9 |
| Headquarters | San Diego, CA, US |
| IPO date | 2021-08-13 |
| Website | www.dermatarx.com |
What you can see for DRMA on Tickr
Live DRMA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DRMA report.
Rankings
FAQ
What is the ticker symbol for Dermata Therapeutics, Inc.?
The ticker symbol for Dermata Therapeutics, Inc. is DRMA, listed on the NASDAQ Capital Market.
What is DRMA?
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated…